Structure |
Chemical Name |
CAS |
MF |
![Itraconazole iMpurity 4](/) |
Itraconazole iMpurity 4 |
|
|
![Ozagrel Impurity 2](/) |
Ozagrel Impurity 2 |
|
|
![Olaparib Impurity 22](/) |
Olaparib Impurity 22 |
|
|
![Irbesartan Impurity 14](/CAS/20200119/GIF/CB04918833.gif) |
Irbesartan Impurity 14 |
133690-91-2 |
C25H28N6O |
![Febuxostat Impurity 25](/CAS/20211123/GIF/1643131-89-8.gif) |
Febuxostat Impurity 25 |
1643131-89-8 |
C17H20N2O4S |
![Pregabalin Impurity 3](/CAS/20211123/GIF/1928754-83-9.gif) |
Pregabalin Impurity 3 |
1928754-83-9 |
C12H22O3 |
![Bosutinib Impurity 6](/) |
Bosutinib Impurity 6 |
|
|
![Ticagrelor Impurity 49](/) |
Ticagrelor Impurity 49 |
2376278-80-5 |
|
![Edoxaban Impurity 14](/) |
Edoxaban Impurity 14 |
|
|
![Indacaterol Impurity 3](/CAS/20210305/GIF/2250243-41-3.gif) |
Indacaterol Impurity 3 |
2250243-41-3 |
C26H32N2O3 |
![Canagliflozin Impurity 11](/) |
Canagliflozin Impurity 11 |
|
|
![Oseltamivir Impurity 22](/) |
Oseltamivir Impurity 22 |
|
|
![Riociguat IMpurtiy B](/) |
Riociguat IMpurtiy B |
|
|
![Silodosin Impurity C](/) |
Silodosin Impurity C |
|
|
![Dexmedetomidine-025](/CAS/20200611/GIF/2250242-52-3.gif) |
Dexmedetomidine-025 |
2250242-52-3 |
C20H22N2 |
![pranoprofen impurity 15](/) |
pranoprofen impurity 15 |
|
|
![Mono-Hydroxy Sugammadex](/CAS/20211123/GIF/2376607-99-5.gif) |
Mono-Hydroxy Sugammadex |
2376607-99-5 |
C69H109NaO47S7 |
![Metronidazole impurity A](/) |
Metronidazole impurity A |
|
|
![Sulpiride Impurity 6](/) |
Sulpiride Impurity 6 |
|
|
![Cefminox Impurity A](/) |
Cefminox Impurity A |
|
|
![Cefminox Impurity F](/) |
Cefminox Impurity F |
|
|
![IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)](/CAS/20180808/GIF/748812-53-5.gif) |
IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE) |
748812-53-5 |
C25H30N6O2 |
![FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE)](/CAS/GIF/217636-48-1.gif) |
FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE) |
217636-48-1 |
C24H27ClO6 |
![(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ&](/CAS/GIF/120570-09-4.gif) |
(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ& |
120570-09-4 |
C15H24Cl2N2 |
![VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE)](/CAS/GIF/1794-55-4.gif) |
VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE) |
1794-55-4 |
C26H37ClN2O4 |
![N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate](/CAS/20210111/GIF/155913-32-9.gif) |
N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate |
155913-32-9 |
C38H49NO11S |
![1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride](/CAS/20200119/GIF/CB05417124.gif) |
1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride |
|
C24H38Cl2N4O4S2 |
![Mupirocin iMpurity 5](/CAS/20200119/GIF/CB05417654.gif) |
Mupirocin iMpurity 5 |
|
C26H44O9 |
![Tolvaptan Impurity 11](/CAS/20200611/GIF/150683-27-5.gif) |
Tolvaptan Impurity 11 |
150683-27-5 |
C25H23ClN2O3 |
![methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate](/CAS/20210305/GIF/1638785-19-9.gif) |
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate |
1638785-19-9 |
C13H15ClO3 |
![1155863-81-2](/CAS/20210111/GIF/1155863-81-2.gif) |
1155863-81-2 |
1155863-81-2 |
C23H19F2N3O6 |
![1175018-73-1](/CAS/20210111/GIF/1175018-73-1.gif) |
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
![Clopidogrel Impurity 44](/CAS/20200331/GIF/CB05430813.gif) |
Clopidogrel Impurity 44 |
|
C15H14ClNO2S |
![5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate](/CAS/20200331/GIF/949155-13-9.gif) |
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
![Nifedipine impurity 06](/CAS/20200119/GIF/CB05432291.gif) |
Nifedipine impurity 06 |
|
C19H22N2O6 |
![Moxifloxacin Impurity 10](/) |
Moxifloxacin Impurity 10 |
|
|
![Ticagrelor Impurity 11](/) |
Ticagrelor Impurity 11 |
|
|
![Parecoxib Impurity 18](/) |
Parecoxib Impurity 18 |
|
|
![Teneligliptin Impurity 9 DiHCl](/) |
Teneligliptin Impurity 9 DiHCl |
|
|
![Pramipexole Impurity Z2](/) |
Pramipexole Impurity Z2 |
|
|
![1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl-](/CAS/20200119/GIF/962-95-8.gif) |
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
![Cabozantinib Impurity 50](/CAS/20210111/GIF/202917-05-3.gif) |
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
![Landiolol impurity U](/) |
Landiolol impurity U |
|
|
![Teneligliptin Impurity 15](/) |
Teneligliptin Impurity 15 |
|
|
![Nicergoline EP Impurity I](/) |
Nicergoline EP Impurity I |
|
|
![Carbamic acid, N-[(4-methylphenyl)sulfonyl]-](/CAS/20200331/GIF/107628-27-3.gif) |
Carbamic acid, N-[(4-methylphenyl)sulfonyl]- |
107628-27-3 |
C8H9NO4S |
![9H-Purin-6-amine, 9-(2-chloropropyl)-](/CAS/20200119/GIF/50615-40-2.gif) |
9H-Purin-6-amine, 9-(2-chloropropyl)- |
50615-40-2 |
C8H10ClN5 |
![Hyoscine Butylbromide EP Impurity G](/) |
Hyoscine Butylbromide EP Impurity G |
|
|
![Cinacalcet Impurity 38 HCl](/CAS/20211123/GIF/938177-81-2.gif) |
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
![Norepinephrine Impurity 23](/CAS/20200119/GIF/1528622-09-4.gif) |
Norepinephrine Impurity 23 |
1528622-09-4 |
C9H13NO3 |
![Brexpiprazole Impurity 77](/CAS/20210111/GIF/1783311-11-4.gif) |
Brexpiprazole Impurity 77 |
1783311-11-4 |
C12H14N2S |
![(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol](/CAS/20200119/GIF/114218-35-8.gif) |
(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol |
114218-35-8 |
C15H26ClNO3 |
![1-Pentanone, 1-(2-hydroxy-5-methylphenyl)-](/CAS/20200331/GIF/150033-77-5.gif) |
1-Pentanone, 1-(2-hydroxy-5-methylphenyl)- |
150033-77-5 |
C12H16O2 |
![PLSQ-001 TM4-QJ](/CAS/20200611/GIF/1227162-74-4.gif) |
PLSQ-001 TM4-QJ |
1227162-74-4 |
C18H24N2O2 |
![(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid](/CAS/20200331/GIF/CB05559992.gif) |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid |
2101641-92-1 |
C11H17NO4 |
![2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3)](/CAS/20211123/GIF/2095467-43-7.gif) |
2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3) |
2095467-43-7 |
C15H20ClN3 |
![Droxidopa Impurity 4](/CAS/20210305/GIF/55382-14-4.gif) |
Droxidopa Impurity 4 |
55382-14-4 |
C31H29NO7 |
![(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol](/) |
(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol |
|
|
![Dapagliflozin Impurity (MW:423Da)](/) |
Dapagliflozin Impurity (MW:423Da) |
|
|
![Ramipril - Isomer Impurity 1](/) |
Ramipril - Isomer Impurity 1 |
|
|
![Aripiprazole peroxide degradation Impurity (MW:480Da)](/) |
Aripiprazole peroxide degradation Impurity (MW:480Da) |
|
|
![Fosinopril Sodium Impurity A (Fosinoprilat)](/) |
Fosinopril Sodium Impurity A (Fosinoprilat) |
|
|
![Dapoxetine Impurity 40](/) |
Dapoxetine Impurity 40 |
|
|
![Doxofylline Impurity 15](/) |
Doxofylline Impurity 15 |
|
|
![Iohexol Impurity 10](/) |
Iohexol Impurity 10 |
|
|
![Benzylpenicillin EP(CP) Impurity F](/) |
Benzylpenicillin EP(CP) Impurity F |
|
|
![Flucloxacillin sodium EP Impurity A](/) |
Flucloxacillin sodium EP Impurity A |
|
|
![Nilotinib Impurity 28](/CAS/20200515/GIF/1807607-72-2.gif) |
Nilotinib Impurity 28 |
1807607-72-2 |
C28H20F3N7O3 |
![Escitalopram Acid Impurity](/CAS/20200611/GIF/1133881-04-5.gif) |
Escitalopram Acid Impurity |
1133881-04-5 |
C20H22FNO3 |
![1,3,6,10,14-Hexadecapentaene, 3,7,11,15-tetramethyl-, (3E,6E,10E)-](/CAS/20200515/GIF/77898-97-6.gif) |
1,3,6,10,14-Hexadecapentaene, 3,7,11,15-tetramethyl-, (3E,6E,10E)- |
77898-97-6 |
C20H32 |
![BROMOCRIPTINE IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB0587422.gif) |
BROMOCRIPTINE IMPURITY A |
|
C32H40BrN5O5 |
![LORATADINE IMPURITY F](/StructureFile/ChemBookStructure22/GIF/CB0588429.gif) |
LORATADINE IMPURITY F |
|
C22H23ClN2O2 |
![ZIDOVUDINE IMPURITY A](/) |
ZIDOVUDINE IMPURITY A |
|
|
![Propanoic acid, 2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl-, 1-(1,1-dimethylethyl) ester](/CAS/20200515/GIF/330944-50-8.gif) |
Propanoic acid, 2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl-, 1-(1,1-dimethylethyl) ester |
330944-50-8 |
C17H25N5O8S2 |
![Canagliflozin Peroxide Impurity](/CAS/20210111/GIF/2247196-28-5.gif) |
Canagliflozin Peroxide Impurity |
2247196-28-5 |
C24H25FO7S |
![(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-2-naphthalenemethanamine Hydrochloride](/CAS/20210111/GIF/2200269-28-7.gif) |
(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-2-naphthalenemethanamine Hydrochloride |
2200269-28-7 |
C22H23ClF3N |
![Ceftazidime Double Mother Nucleus Impurity](/) |
Ceftazidime Double Mother Nucleus Impurity |
|
|
![Cefuroxime Sodium Trans Impurity I,(E)-Cefuroxime Sodium Impurity I](/) |
Cefuroxime Sodium Trans Impurity I,(E)-Cefuroxime Sodium Impurity I |
|
|
![Hydroxy TorseMide](/CAS/GIF/99300-68-2.gif) |
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
![Hydroxy Varenicline N-Trifluoroacetate](/CAS/GIF/357426-10-9.gif) |
Hydroxy Varenicline N-Trifluoroacetate |
357426-10-9 |
C15H12F3N3O2 |
![N-ForMyl Valacyclovir](/CAS/GIF/847670-62-6.gif) |
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |
![2-Fluorobiphenyl-4-carboxylic Acid](/CAS/GIF/137045-30-8.gif) |
2-Fluorobiphenyl-4-carboxylic Acid |
137045-30-8 |
C13H9FO2 |
![Theophyllidine Hydrochloride](/CAS/GIF/116131-08-9.gif) |
Theophyllidine Hydrochloride |
116131-08-9 |
C6H10ClN4O |
![1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole](/CAS/GIF/887583-89-3.gif) |
1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole |
887583-89-3 |
C19H20N4 |
![Tetracyclics compound impurities](/) |
Tetracyclics compound impurities |
|
|
![Urapidil Impurity](/CAS/20211123/GIF/770-42-3.gif) |
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
![N'-(1-Methylazepan-4-yl)benzohydrazine](/CAS/GIF/117078-69-0.gif) |
N'-(1-Methylazepan-4-yl)benzohydrazine |
117078-69-0 |
C14H22ClN3O |
![3-(3-Chloropropyl)-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one](/CAS/20180808/GIF/85175-65-1.gif) |
3-(3-Chloropropyl)-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
85175-65-1 |
C15H20ClNO3 |
![N-DesMethyl TelMisartan](/CAS/GIF/144701-81-5.gif) |
N-DesMethyl TelMisartan |
144701-81-5 |
C32H28N4O2 |
![N-De[2-(Methylsulfonyl)ethyl] Lapatinib](/CAS/GIF/697299-82-4.gif) |
N-De[2-(Methylsulfonyl)ethyl] Lapatinib |
697299-82-4 |
C26H20ClFN4O2 |
![N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide](/CAS/GIF/957470-58-5.gif) |
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide |
957470-58-5 |
C24H24F2N4O5S |
![3-Oxo Rosuvastatin SodiuM Salt](/CAS/GIF/1346606-28-7.gif) |
3-Oxo Rosuvastatin SodiuM Salt |
1346606-28-7 |
C22H25FN3NaO6S |
![Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride)](/CAS/20150408/GIF/246021-75-0.gif) |
Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride) |
246021-75-0 |
C10H16ClN5O2 |
![Olopatadine USP RC B](/CAS/20150408/GIF/173174-07-7.gif) |
Olopatadine USP RC B |
173174-07-7 |
C21H23NO4 |
![Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid)](/CAS/20180808/GIF/108313-11-7.gif) |
Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) |
108313-11-7 |
C22H30N2O5 |
![4'-(Difluoromethoxy)acetanilide](/CAS/GIF/22236-11-9.gif) |
4'-(Difluoromethoxy)acetanilide |
22236-11-9 |
C9H9F2NO2 |
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-28-2.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-28-2 |
C24H30ClN7O4S |
![N-carbaMoyl-2-Methyl benzene sulfonaMide](/CAS/20130318/GIF/CB22582658.gif) |
N-carbaMoyl-2-Methyl benzene sulfonaMide |
39051-77-9 |
C8H10N2O3S |
![Capecitabin iMpurity](/CAS/20210111/GIF/71609-08-0.gif) |
Capecitabin iMpurity |
71609-08-0 |
C9H12FN3O4 |
![4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride)](/) |
4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride) |
|
|